Bioactive natural products with anti-herpes simplex virus properties

Journal of Pharmacy and Pharmacology

Volumn 67, Issue 10, 2015, Pages 1325-1336

  Hassan, Sherif T S ^a,b   Masarčíková, Radka ^a   Berchová, Kateřina ^b  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^b CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

Author keywords

antiviral agents; bioactive compounds; herpes simplex virus; natural products; nucleoside analogues

Indexed keywords

ALKALOID DERIVATIVE; ANTIVIRUS AGENT; NUCLEOSIDE DERIVATIVE; PEPTIDE DERIVATIVE; PHENOL DERIVATIVE; POLYSACCHARIDE; PROPOLIS; PROTEIN DERIVATIVE; TERPENE DERIVATIVE; BIOLOGICAL PRODUCT;

ACTINOMADURA; ACTINOMADURA NAMIBIENSIS; AGARICUS; AGARICUS BRASILIENSIS; ANTIVIRAL ACTIVITY; ARTHROSPIRA PLATENSIS; BASELLA RUBRA; CRYPTONEMIA CRENULATA; EUPHORBIA JOLKINI; GANODERMA LUCIDUM; GRACILARIA; GRACILARIA CORTICATA; GRIFOLA FRONDOSA; GYMNOGONGRUS GRIFFITHSIAE; HERPES SIMPLEX; HETEROMETRUS PETERSII; HUMAN; MEDICINAL PLANT; MELIA AZEDARACH; MYCALE; NONHUMAN; PANAX NOTOGINSENG; POISONOUS ANIMAL; PRUNELLA VULGARIS; RED ALGA; REVIEW; RHUS JAVANICA; SCINAIA HATEI; SPONGE (PORIFERA); STELLARIA MEDIA; TETHYA CRYPTA; TRICHOSANTHES KIRILOWII; TRIPTERYGIUM WILFORDII; ANIMAL; ANTIVIRAL RESISTANCE; DRUG DESIGN; HERPES SIMPLEX VIRUS 1; ISOLATION AND PURIFICATION; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; DRUG DESIGN; DRUG RESISTANCE, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS;

EID: 84941188303     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12436     Document Type: Review

References (115)

1. Paludan SR, et al. Recognition of herpesviruses by the innate immune system. Nat Rev Immunol 2011; 11: 143-154.
2. Field HJ,. Persistent herpes simplex virus infection and mechanisms of virus drug resistance. Eur J Clin Microbiol Infect Dis 1989; 8: 671-680.
3. Simpson D, Lyseng-Williamson KA,. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes. Drugs 2006; 66: 2397-2416.
4. Levin MJ, et al. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis 2004; 39 (Suppl. 5): S248-S257.
5. Piret J, Boivin G,. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 2011; 55: 459-472.
6. Markham A, Faulds D,. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 1994; 48: 455-484.
7. Reusser P,. Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts. Expert Opin Investig Drugs 2001; 10: 1745-1753.
8. Villarreal EC,. Current and potential therapies for the treatment of herpesvirus infections. Prog Drug Res 2001; 56: 77-120.
9. Reusser P,. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 1996; 33: 235-248.
10. Flowerdew SE, et al. Characterization of neuronal populations in the human trigeminal ganglion and their association with latent herpes simplex virus-1 infection. PLoS ONE 2013; 8: e83603.
11. Hamza MA, et al. Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons. Neurobiol Dis 2007; 25: 553-560.
12. Tan HH, Goh CL,. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol 2006; 7: 13-29.
13. Frobert E, et al. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France. Antiviral Res 2014; 111C: 36-41.
14. Imura K, et al. Herpes simplex virus type 1 infection in two pet Marmosets in Japan. J Vet Med Sci 2014; 76: 1667-1670.
15. Shannon TE, Griffin SL,. Managing aggression in global amnesia following herpes simplex virus encephalitis: the case of E.B. Brain Inj 2014; 29: 118-124.
16. Kopp SJ, et al. Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV. Pediatr Res 2014; 8: 528-534.
17. Evans CM, et al. Management of herpesvirus infections. Int J Antimicrob Agents 2013; 42: 119-128.
18. Debbab A, et al. Bioactive compounds from marine bacteria and fungi. Microb Biotechnol 2010; 3: 544-563.
19. Penesyan A, et al. Development of novel drugs from marine surface associated microorganisms. Mar Drugs 2010; 8: 438-459.
20. Newman D, Cragg G,. Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod 2004; 67: 1216-1238.
21. Sagar S, et al. Antiviral lead compounds from marine sponges. Mar Drugs 2010; 8: 2619-2638.
22. Kitazato K, et al. Viral infectious disease and natural products with antiviral activity. Drug Discov Ther 2007; 1: 14-22.
23. Kleymann G,. Agents and strategies in development for improved management of herpes simplex virus infection and disease. Expert Opin Investig Drugs 2005; 14: 135-161.
24. Yeung-Yue KA, et al. The management of herpes simplex virus infections. Curr Opin Infect Dis 2002; 15: 115-122.
25. Faulkner DJ,. Marine natural products. Nat Prod Rep 2002; 19: 1-48.
26. Perry NB, et al. Antiviral and antitumor agents from a New Zealand sponge, Mycale sp. 2. Structures and solution conformations of mycalamides A and B. J Org Chem 1990; 55: 223-227.
27. Mandal P, et al. Xylans from Scinaia hatei: structural features, sulfation and anti-HSV activity. Int J Biol Macromol 2010; 46: 173-178.
28. Talarico LB, et al. Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata. Int J Biol Macromol 2004; 34: 63-71.
29. Duarte ME, et al. Inhibitory effect of sulfated galactans from the marine alga Bostrychia montagnei on herpes simplex virus replication in vitro. Phytomedicine 2001; 8: 53-58.
30. Hayashi T, et al. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod 1996; 59: 83-87.
31. Chattopadhyay K, et al. Polysaccharides from Gracilaria corticata: sulfation, chemical characterization and anti-HSV activities. Int J Biol Macromol 2008; 43: 346-351.
32. Cardozo FT, et al. Antiherpetic activity of a sulfated polysaccharide from Agaricus brasiliensis mycelia. Antiviral Res 2011; 92: 108-114.
33. Dong CX, et al. Structures and anti-HSV-2 activities of neutral polysaccharides from an edible plant, Basella rubra L. Int J Biol Macromol 2012; 50: 245-249.
34. Xu HX, et al. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res 1999; 44: 43-54. Antiviral Research. 1999, vol. 44, issue 1, s. 2854-2864.
35. Eo SK, et al. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol 2000; 72: 475-481.
36. Gu CQ, et al. Isolation, identification and function of a novel anti-HSV-1 protein from Grifola frondosa. Antiviral Res 2007; 75: 250-257.
37. Shan Y, et al. Purification and characterization of a novel anti-HSV-2 protein with antiproliferative and peroxidase activities from Stellaria media. Acta Biochim Biophys Sin (Shanghai) 2013; 45: 649-655.
38. Huang H, et al. Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells. Life Sci 2006; 79: 1287-1292.
39. Chen GF, et al. Protective effects of trichosanthin in herpes simplex virus-1 encephalitis in mice. Zhongguo Dang Dai Er Ke Za Zhi 2006; 8: 239-241.
40. Albiol Matanic VC, Castilla V,. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int J Antimicrob Agents 2004; 23: 382-389.
41. Cowan MM,. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564-582.
42. Jenssen H, et al. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19: 491-511.
43. Hong W, et al. Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1. Antiviral Res 2014; 102: 1-10.
44. Shestakov A, et al. Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice. Antiviral Res 2013; 100: 455-459.
45. Jenssen H,. Anti herpes simplex virus activity of lactoferrin/lactoferricin-an example of antiviral activity of antimicrobial protein/peptide. Cell Mol Life Sci 2005; 62: 3002-3013.
46. Yasin B, et al. Evaluation of the inactivation of infectious herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis 2000; 19: 187-194.
47. Férir G, et al. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS ONE 2013; 8: e64010.
48. Petrera E, Coto CE,. Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection. Phytother Res 2009; 23: 1771-1777.
49. Pifarré MP, et al. Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice. Exp Eye Res 2002; 75: 327-334.
50. Barquero AA, Villamil SM,. Combined activity of meliacin and foscarnet against different strains of herpes simplex virus type 1 using a three-dimensional model. Rev Argent Microbiol 1997; 29: 32-37.
51. Barquero AA, et al. Antiviral activity of meliacine on the replication of a thymidine kinase-deficient mutant of herpes simplex virus type 1 alone and in combination with acyclovir. Int J Antimicrob Agents 1997; 9: 49-55.
52. Mundinger TA, Efferth T,. Herpes simplex virus: drug resistance and new treatment options using natural products (Review). Mol Med Rep 2008; 5: 611-616.
53. Armaka M, et al. Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1. Antiviral Res 1999; 43: 79-92.
54. Astani A, et al. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother Res 2010; 24: 673-679.
55. Hayashi K, et al. Characterization of antiviral activity of a sesquiterpene, triptofordin C-2. J Antimicrob Chemother 1996; 37: 759-768.
56. Cheng HY, et al. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. J Antimicrob Chemother 2004; 53: 577-583.
57. Kurokawa M, et al. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. J Pharmacol Exp Ther 1999; 289: 72-78.
58. Kim M, et al. Antiviral effects of 28-deacetylsendanin on herpes simplex virus-1 replication. Antiviral Res 1999; 43: 103-112.
59. Bueno CA, et al. A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent. Virus Res 2009; 141: 47-54.
60. Pei Y, et al. Notoginsenoside ST-4 inhibits virus penetration of herpes simplex virus in vitro. J Asian Nat Prod Res 2011; 6: 498-504.
61. Utsunomiya T, et al. Glycyrrhizin (20 beta-carboxy-11-oxo-30-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunol Lett 1995; 44: 59-66.
62. Son M, et al. Bioactive activities of natural products against herpesvirus infection. J Microbiol 2013; 51: 545-551.
63. Chiang LC, et al. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med 2003; 69: 600-604.
64. Ikeda K, et al. Inhibition of multiplication of herpes simplex virus by caffeic acid. Int J Mol Med 2011; 28: 595-598.
65. Kutluay SB, et al. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology 2008; 373: 239-247.
66. Zandi K, et al. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in vero cell line. Nat Prod Commun 2010; 5: 1935-1938.
67. Yarmolinsky L, et al. Potent antiviral flavone glycosides from Ficus benjamina leaves. Fitoterapia 2011; 83: 362-367.
68. Buckwold VE, et al. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res 2004; 61: 57-62.
69. Meyer JJ, et al. Antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens. J Ethnopharmacol 1997; 56: 165-169.
70. Orhan DD, et al. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res 2010; 165: 496-504.
71. Yang CM, et al. Euphorbia thymifolia suppresses herpes simplex virus-2 infection by directly inactivating virus infectivity. Clin Exp Pharmacol Physiol 2005; 32: 346-349.
72. Yang CM, et al. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-beta-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnopharmacol 2007; 110: 555-558.
73. Cheng HY, et al. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral Res 2002; 55: 447-455.
74. de Oliveira A, et al. Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate. Food Chem Toxicol 2013; 52: 207-215.
75. Kuo YC, et al. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis. Antimicrob Agents Chemother 2002; 46: 2854-2864.
76. Esquenazi D, et al. Antimicrobial and antiviral activities of polyphenolics from Cocos nucifera Linn. (Palmae) husk fiber extract. Res Microbiol 2002; 153: 647-652.
77. Xiong HR, et al. The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo. J Ethnopharmacol 2011; 133: 718-723.
78. Hsiang CY, Ho TY,. Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures. Br J Pharmacol 2008; 155: 227-235.
79. Zandi K, et al. Antiviral activity of aloe vera against herpes simplex virus type 2: an in vitro study. Afr J Biotechnol 2007; 6: 1770-1773.
80. Kitazato K, et al. Viral infectious disease and natural products with antiviral activity. Drug Discov Ther 2007; 1: 14-22.
81. Zhang LA, et al. An unusual indole alkaloid with anti-adenovirus and anti-HSV activities from Alstonia scholaris. Tetrahedron Lett 2014; 55: 1815-1827.
82. Chin LW, et al. Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol 2010; 155: 1933-1941.
83. Nawawi A, et al. In vivo antiviral activity of Stephania cepharantha against herpes simplex virus type-1. Phytother Res 2001; 6: 497-500.
84. Nakano M, et al. Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs. Antiviral Res 1998; 39: 25-33.
85. Bourne N, et al. Civamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpes. Antimicrob Agents Chemother 1999; 43: 2685-2688.
86. Ren Z1, et al. In vitro anti-viral activity of the total alkaloids from Tripterygium hypoglaucum against herpes simplex virus type 1. Virol Sin 2010; 25: 107-114.
87. Souza TM, et al. The alkaloid 4-methylaaptamine isolated from the sponge Aaptos aaptos impairs Herpes simplex virus type 1 penetration and immediate-early protein synthesis. Planta Med 2007; 73: 200-205.
88. Sakai R, et al. Manzamine A, a novel antitumor alkaloid from a sponge. J Am Chem Soc 1986; 108: 6404-6405.
89. Palem JR, et al. Manzamine a as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells. Planta Med 2011; 77: 46-51.
90. Hamuy R, Berman B,. Topical antiviral agents for herpes simplex virus infections. Drugs Today (Barc) 1998; 34: 1013-1025.
91. Terezhalmy GT, et al. The use of water-soluble bioflavonoid-ascorbic acid complex in the treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol 1978; 45: 56-62.
92. Fridlender B, et al. Selective inhibition of herpes simplex virus type I DNApolymerase by zinc ions. Virology 1978; 84: 551-554.
93. Gupta P, Rapp F,. Effect of zinc ions on synthesis of herpes simplex virus type 2-induced polypeptides. Proc Soc Exp Biol Med 1976; 152: 455-458.
94. Gordon YJ, et al. Irreversible inhibition of herpes simplex virus replication in BSC-1 cells by zinc ions. Antimicrob Agents Chemother 1975; 8: 377-380.
95. Tennican P, et al. Topical zinc in the treatment of mice infected intravaginally with herpes genitalis virus. Proc Soc Exp Biol Med 1980; 164: 593-597.
96. Tennican PO, et al. The diverse effects of topical and systemic administration of zinc on the virulence of herpes simplex genitalis. Life Sci 1979; 24: 1877-1883.
97. Nead DE,. Effective vitamin E treatment for ulcerative herpetic lesions. Dent Surv 1976; 52: 50-51.
98. Skinner GR, et al. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol 1980; 168: 139-148.
99. Lieb J,. Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate. Med Hypotheses 1981; 7: 885-890.
100. Skinner GR,. Lithium ointment for genital herpes. Lancet 1983; 2: 288.
101. Schnitzler P, et al. Antiviral activity and mode of action of propolis extracts and selected compounds. Phytother Res 2010; 24 (Suppl. 1): S20-S28.
102. Huleihel M, Isanu V,. Anti-herpes simplex virus effect of an aqueous extract of propolis. Isr Med Assoc J 2002; 4 (11 Suppl.): 923-927.
103. Sartori G, et al. Protective effect of brown Brazilian propolis against acute vaginal lesions caused by herpes simplex virus type 2 in mice: involvement of antioxidant and anti-inflammatory mechanisms. Cell Biochem Funct 2012; 30: 1-10.
104. Yoosook C, et al. Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine 2000; 6: 411-419.
105. Abad MJ, et al. Antiviral activity of Bolivian plant extracts. Gen Pharmacol 1999; 32: 499-503.
106. Andrighetti-Fröhner CR1, et al. Antiviral evaluation of plants from Brazilian Atlantic Tropical Forest. Fitoterapia 2005; 76: 374-378.
107. Li T, Peng T,. Traditional Chinese herbal medicine as a source of molecules with antiviral activity. Antiviral Res 2013; 97: 1-9.
108. Soltan MM, Zaki AK,. Antiviral screening of forty-two Egyptian medicinal plants. J Ethnopharmacol 2009; 126: 102-107.
109. Yarmolinsky L, et al. Antiviral activity of ethanol extracts of Ficus binjamina and Lilium candidum in vitro. N Biotechnol 2009; 26: 307-313.
110. Sassi AB, et al. Antiviral activity of some Tunisian medicinal plants against herpes simplex virus type 1. Nat Prod Res 2008; 22: 53-65.
111. Gebre-Mariam T, et al. Antiviral activities of some Ethiopian medicinal plants used for the treatment of dermatological disorders. J Ethnopharmacol 2006; 104: 182-187.
112. Locher CP, et al. Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 1995; 49: 23-32.
113. Thompson KD,. Herbal extracts and compounds active against herpes simplex virus. Adv Phytomed 2006; 2: 65-86.
114. Rattanathongkom A, et al. Evaluation of chikusetsusaponin IV a isolated from Alternanthera philoxeroides for its potency against viral replication. Planta Med 2009; 75: 829-835.
115. Ichiba T, et al. 8-Hydroxymanzamine A, a beta-carboline alkaloid from a sponge, Pachypellina sp. J Nat Prod 1994; 57: 168-170.